These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 33974471)

  • 1. Novel hyaluronic acid oligosaccharide-loaded and CD44v6-targeting oxaliplatin nanoparticles for the treatment of colorectal cancer.
    Du W; Yang X; He S; Wang J; Guo Y; Kou B; Jiang Y; Bian P; Li B; Yin L
    Drug Deliv; 2021 Dec; 28(1):920-929. PubMed ID: 33974471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyaluronic acid oligosaccharide-modified zeolitic imidazolate framework-8 nanoparticles loaded with oxaliplatin as a targeted drug-delivery system for colorectal cancer therapy.
    Li B; Zhang Z; He S; Du W; Yang X; Kou B; Jiang Y; Bian P; Yin L
    Nanomedicine (Lond); 2023 May; 18(12):891-905. PubMed ID: 37409459
    [No Abstract]   [Full Text] [Related]  

  • 3. Folate conjugated hyaluronic acid coated alginate nanogels encapsulated oxaliplatin enhance antitumor and apoptosis efficacy on colorectal cancer cells (HT29 cell line).
    Shad PM; Karizi SZ; Javan RS; Mirzaie A; Noorbazargan H; Akbarzadeh I; Rezaie H
    Toxicol In Vitro; 2020 Jun; 65():104756. PubMed ID: 31884114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyaluronic Acid-Zein Core-Shell Nanoparticles Improve the Anticancer Effect of Curcumin Alone or in Combination with Oxaliplatin against Colorectal Cancer via CD44-Mediated Cellular Uptake.
    Liu L; Yang S; Chen F; Cheng KW
    Molecules; 2022 Feb; 27(5):. PubMed ID: 35268597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved anti-colorectal carcinomatosis effect of tannic acid co-loaded with oxaliplatin in nanoparticles encapsulated in thermosensitive hydrogel.
    Ren Y; Li X; Han B; Zhao N; Mu M; Wang C; Du Y; Wang Y; Tong A; Liu Y; Zhou L; You C; Guo G
    Eur J Pharm Sci; 2019 Feb; 128():279-289. PubMed ID: 30553061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of HA oligosaccharide-loaded nanoparticles to breach the endogenous hyaluronan glycocalyx for breast cancer therapy.
    Yang C; Liu Y; He Y; Du Y; Wang W; Shi X; Gao F
    Biomaterials; 2013 Sep; 34(28):6829-38. PubMed ID: 23764114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel mitochondrial targeting charge-reversal polysaccharide hybrid shell/core nanoparticles for prolonged systemic circulation and antitumor drug delivery.
    Fang L; Zhang W; Wang Z; Fan X; Cheng Z; Hou X; Chen D
    Drug Deliv; 2019 Dec; 26(1):1125-1139. PubMed ID: 31736389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxaliplatin-incorporated micelles eliminate both cancer stem-like and bulk cell populations in colorectal cancer.
    Wang K; Liu L; Zhang T; Zhu YL; Qiu F; Wu XG; Wang XL; Hu FQ; Huang J
    Int J Nanomedicine; 2011; 6():3207-18. PubMed ID: 22238509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor RNA-loaded nanoliposomes increases the anti-tumor immune response in colorectal cancer.
    Dai D; Yin Y; Hu Y; Lu Y; Zou H; Lu G; Wang Q; Lian J; Gao J; Shen X
    Drug Deliv; 2021 Dec; 28(1):1548-1561. PubMed ID: 34286631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Novel Targeted Therapy System for Cervical Cancer:  Co-Delivery System  of  Antisense LncRNA of MDC1 and Oxaliplatin Magnetic Thermosensitive Cationic Liposome Drug Carrier.
    Ye H; Chu X; Cao Z; Hu X; Wang Z; Li M; Wan L; Li Y; Cao Y; Diao Z; Peng F; Liu J; Xu L
    Int J Nanomedicine; 2021; 16():1051-1066. PubMed ID: 33603368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting LAYN inhibits colorectal cancer metastasis and tumor-associated macrophage infiltration induced by hyaluronan oligosaccharides.
    Yang Y; Chen Z; Chu X; Yan Q; He J; Guo Y; Zhao Z; Zhang Y; Hu D; Ding H; Zhao X; Pan Y; Dong H; Wang L; Pan J
    Matrix Biol; 2023 Mar; 117():15-30. PubMed ID: 36805871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo Evaluation of a Novel Estrogen-Targeted PEGylated Oxaliplatin Liposome for Gastric Cancer.
    Sun Y; Xie Y; Tang H; Ren Z; Luan X; Zhang Y; Zhu M; Lv Z; Bao H; Li Y; Liu R; Shen Y; Zheng Y; Pei J
    Int J Nanomedicine; 2021; 16():8279-8303. PubMed ID: 34992365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiRNA-204-5p and oxaliplatin-loaded silica nanoparticles for enhanced tumor suppression effect in CD44-overexpressed colon adenocarcinoma.
    Yang H; Liu Y; Qiu Y; Ding M; Zhang Y
    Int J Pharm; 2019 Jul; 566():585-593. PubMed ID: 31181310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyaluronic acid oligosaccharide modified redox-responsive mesoporous silica nanoparticles for targeted drug delivery.
    Zhao Q; Geng H; Wang Y; Gao Y; Huang J; Wang Y; Zhang J; Wang S
    ACS Appl Mater Interfaces; 2014 Nov; 6(22):20290-9. PubMed ID: 25311422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyaluronic acid-decorated liposomal nanoparticles for targeted delivery of 5-fluorouracil into HT-29 colorectal cancer cells.
    Mansoori B; Mohammadi A; Abedi-Gaballu F; Abbaspour S; Ghasabi M; Yekta R; Shirjang S; Dehghan G; Hamblin MR; Baradaran B
    J Cell Physiol; 2020 Oct; 235(10):6817-6830. PubMed ID: 31989649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioactive Peptides Sensitize Cells to Anticancer Effects of Oxaliplatin in Human Colorectal Cancer Xenografts in Nude Mice.
    Li X; Xia L; Ouyang X; Suyila Q; Su L; Su X
    Protein Pept Lett; 2019; 26(7):512-522. PubMed ID: 30950338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delivery of CD44 shRNA/nanoparticles within cancer cells: perturbation of hyaluronan/CD44v6 interactions and reduction in adenoma growth in Apc Min/+ MICE.
    Misra S; Hascall VC; De Giovanni C; Markwald RR; Ghatak S
    J Biol Chem; 2009 May; 284(18):12432-46. PubMed ID: 19246453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-delivery of 5-fluorouracil and oxaliplatin in novel poly(3-hydroxybutyrate-co-3-hydroxyvalerate acid)/poly(lactic-co-glycolic acid) nanoparticles for colon cancer therapy.
    Handali S; Moghimipour E; Rezaei M; Saremy S; Dorkoosh FA
    Int J Biol Macromol; 2019 Mar; 124():1299-1311. PubMed ID: 30248424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. β-hydroxybutyrate resensitizes colorectal cancer cells to oxaliplatin by suppressing H3K79 methylation in vitro and in vivo.
    Deng M; Yan P; Gong H; Li G; Wang J
    Mol Med; 2024 Jun; 30(1):95. PubMed ID: 38910244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxaliplatin resistance in colorectal cancer cells is mediated via activation of ABCG2 to alleviate ER stress induced apoptosis.
    Hsu HH; Chen MC; Baskaran R; Lin YM; Day CH; Lin YJ; Tu CC; Vijaya Padma V; Kuo WW; Huang CY
    J Cell Physiol; 2018 Jul; 233(7):5458-5467. PubMed ID: 29247488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.